|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||72.15 - 73.33|
|52 Week Range||72.15 - 94.67|
|PE Ratio (TTM)||19.34|
|Earnings Date||Apr 24, 2018 - Apr 30, 2018|
|Forward Dividend & Yield||2.87 (3.69%)|
|1y Target Est||81.79|
Procter & Gamble Co will acquire the consumer health business of Merck for about 3.4 billion euros ($4.2 billion), giving it vitamin brands such as Seven Seas and greater exposure to Latin American and Asian markets. As Sonia Legg reports, the deal was announced shortly before P&G reported better than expected quarterly results.
CNBC's Bob Pisani discovered another reason for the Dow's 400-point plus drop on Tuesday.
After giving back nearly all of its post-earnings gains on the stock market, Anheuser Busch InBev NV (ADR) (NYSE:BUD) resumed its medium-term downtrend. Anheuser-Busch topped over $115 per share when the company reported solid fourth-quarter results. Africa, Latin America, and Australia were particularly good markets in 2017 for Anheuser-Busch.
Kimberly-Clark (KMB) reported an improved sales and earnings performance in 1Q18. The company surpassed analysts’ expectations both on the sales and EPS fronts. However, continued pressure on margins, promotional spending to drive volumes, and lower pricing remained a drag and continued to hurt its margins. The company’s gross margin fell significantly in 1Q18, which prompted a couple of analysts to lower the target price on Kimberly-Clark stock. Jefferies lowered its price target to $102 per share from $110. Meanwhile, Wells Fargo reduced its target price on KMB stock to $92 from $100.
The home and personal care product manufacturers in the US continue to disappoint with their margin performance. Significant inflation in commodities, promotional spending to drive volumes, lower net price realization, and a tough retail environment are taking a toll on the profit margins of the companies operating in this space.
Kimberly-Clark (KMB) sustained its sales momentum in 1Q18. The company’s net sales of $4.7 billion exceeded analysts’ expectations and increased 5.1% on a YoY (year-over-year) basis thanks to the favorable currency rates, which contributed about 3.0% to the top-line growth rate. Plus, investments in brands to support volumes dented the net sales growth rate.
Kimberly-Clark (KMB) reported stronger-than-expected 1Q18 earnings. Kimberly-Clark’s adjusted earnings of $1.71 per share came in ahead of the consensus estimate of $1.69 and rose 8.9% on a YoY (year-over-year) basis. The company has now surpassed analysts’ expectations in three quarters despite pressure on margins from significant inflation in input costs and lower net price realization.
Kimberly-Clark (KMB) reported better-than-expected 1Q18 results on Monday, April 23, 2018. The company’s top-line and bottom-line results surpassed analysts’ expectations. However, investors didn’t care much, and the company’s stock fell about 1.5% as persisting challenges, especially on the margins front, remained a drag.
Like Procter, on the surface, you could make a strong case to own Kimberly-Clark given its release where the company talked about 2% growth and some very strong numbers in consumer tissue -- think Kleenex -- and personal care. Tissue sales in North America increased 6% and developing and emerging markets increased 7%. Kimberly's professional segment increased 5%.
Most analysts covering Church & Dwight (CHD) stock have recommended “hold,” despite the company’s strong sales and earnings performance in the past two quarters and upbeat guidance. Church & Dwight’s sales and adjusted earnings grew by double digits during the last reported quarter, and they are expected to sustain that momentum in 1Q18.
Analysts expect Church & Dwight (CHD) to report strong sales and earnings growth in the upcoming quarter. Church & Dwight is expected to announce its 1Q18 results on May 3, 2018, and analysts expect the company’s top line to rise 11.5% YoY (year-over-year), more than peers’.
Church & Dwight (CHD) stock fell ~6% on Friday, April 20, 2018, after being downgraded by Deutsche Bank to “hold” from “buy.” Its price target was lowered to $50 per share from $56. Investors are skeptical on the prospects of household and personal care product manufacturers, which are facing increased price competition, a challenging retail scenario, and margin headwinds.
The maker of Pampers diapers and Gillette razors said the deal would help it expand its portfolio of consumer healthcare products which includes Vicks cold relief. The Merck unit includes vitamin brands Femibion and Neurobion. The deal follows GlaxoSmithKline agreeing to buy Novartis out of their consumer healthcare joint venture for $13 billion after dropping its pursuit of Pfizer's consumer unit.
In this updated daily bar chart of PG, below, we can see that the bears are still in control of PG. Prices are still in a downtrend with bearish slopes for the 50-day and the 200-day moving averages. The volume of shares traded increased from late January and the daily On-Balance-Volume (OBV) has been trending lower telling us that sellers of PG have been more aggressive.
Based on the insight from the Always #LikeAGirl campaign that half of girls lose confidence at pubertyi, Always is partnering with retailers to encourage girls to pursue their goals and build their confidence.
WHAT: The Tide Loads of Hope Mobile Laundry Unit has been deployed to support relief and recovery efforts in the wake of the recent tornado. The Tide Loads of Hope mobile laundry vehicle will begin services in Greensboro, North Carolina starting on Sunday, April 22nd providing free full-service laundry to residents affected by the severe weather. P&G is working closely in partnership with Matthew 25: Ministries to provide P&G product donations by going in to the neighborhoods of affected residents in the Greensboro area.
Procter & Gamble (PG) continued to report sluggish margins in fiscal 3Q18. The company’s core gross margin fell 110 basis points to 49.4% in fiscal 3Q18 as lower pricing to drive volumes and increased cost pressure more than offset the benefits stemming from cost and productivity savings.
Lower pricing adversely impacted Procter & Gamble’s (PG) sales across product segments amid increased competitive activity. However, favorable currency rates and improved volumes drove top-line growth.
The Consumer Staples Select Sector SPDR ETF (XLP)—a basket of 34 companies in the sector—lost almost 3% Thursday, largely caused by the 16% drop in tobacco giant Philip Morris (PM), after its cigarette shipments fell more than expected and its heated-tobacco product—an area with high expectations for rapid growth—was experiencing headwinds in key market Japan. The company cited higher commodities and transportation costs as the cause of narrower margins, and admitted sales growth "has been challenging in a very difficult market environment." These three companies collectively comprise approximately 25% of the consumer-staples sector, which helps explain why the Consumer Staples ETF dropped 4.1% last week. It's no secret that Amazon.com (AMZN) and Walmart (WMT) have essentially made the retail space an oligopoly, says Mike O’Rourke, chief market strategist of JonesTrading.
Procter & Gamble (PG) reported net sales of $16.3 billion, a rise of 4.3% YoY (year-over-year), which exceeded analysts’ expectations. As expected, Procter & Gamble’s top line benefitted from improved volumes and favorable currency rates. Also, the improved mix contributed 1% to the net sales growth rate.
Procter & Gamble (PG) reported adjusted earnings of $1.00 per share in fiscal 3Q18, which came in ahead of analysts’ estimate of $0.98 and increased 4.2% YoY (year-over-year). Moreover, Procter & Gamble has now surpassed analysts’ earnings expectations in the past 12 quarters. However, what didn’t sit well with investors was the company’s low EPS growth rate, especially given the benefits from favorable currency rates, the low tax rate environment, and strong productivity savings.